Literature DB >> 8391255

Protein kinase C activity is not involved in N-formylmethionyl-leucyl-phenylalanine-induced phospholipase D activation in human neutrophils, but is essential for concomitant NADPH oxidase activation: studies with a staurosporine analogue with improved selectivity for protein kinase C.

G C Kessels1, K H Krause, A J Verhoeven.   

Abstract

Stimulation of human neutrophils by the receptor agonist N-formylmethionyl-leucyl-phenylalanine (fMLP) results in a respiratory burst, catalysed by an NADPH oxidase. Concomitantly, phospholipase D (PLD) is activated. To investigate the role of protein kinase C (PKC) in these neutrophil responses, we have compared the effects of staurosporine and a structural analogue of staurosporine (cgp41251), that reflects a higher selectivity towards PKC [Meyer, Regenass, Fabbro, Alteri, Rösel, Müller, Caravatti and Matter (1989) Int. J. Cancer 43, 851-856]. Both staurosporine and cgp41251 dose-dependently inhibited the production of superoxide induced by phorbol 12-myristate 13-acetate (PMA). Both compounds also caused inhibition of the fMLP-induced respiratory burst, but with a lower efficacy during the initiation phase of this response. This latter observation cannot be taken as evidence against PKC involvement in the activation of the respiratory burst, because pretreatment of neutrophils with ionomycin before PMA stimulation also results in a lower efficacy of inhibition. Activation of PLD by fMLP was enhanced in the presence of staurosporine, but not in the presence of cgp41251. Enhancement of PLD activation was also observed in the presence of H-89, an inhibitor of cyclic-AMP-dependent protein kinase (PKA). Both staurosporine and H-89 reversed the dibutyryl-cyclic-AMP-induced inhibition of PLD activation, whereas cgp41251 was without effect. These results indicate that the potentiating effect of staurosporine on PLD activation induced by fMLP does not reflect a feedback inhibition by PKC activation, but instead a feedback inhibition by PKC activation. Taken together, our results indicate that in human neutrophils: (i) PKC activity is not essential for fMLP-induced activation of PLD; (ii) PKC activity does play an essential role in the activation of the respiratory burst by fMLP, other than mediating or modulating PLD activation; (iii) there exists a negative-feedback mechanism on fMLP-induced PLD activation by concomitant activation of PKA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391255      PMCID: PMC1134181          DOI: 10.1042/bj2920781

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Chemoattractant-elicited alterations of cAMP levels in human polymorphonuclear leukocytes require a Ca2+-dependent mechanism which is independent of transmembrane activation of adenylate cyclase.

Authors:  M W Verghese; K Fox; L C McPhail; R Snyderman
Journal:  J Biol Chem       Date:  1985-06-10       Impact factor: 5.157

Review 2.  Protein kinase C and the activation of the human neutrophil NADPH-oxidase.

Authors:  A I Tauber
Journal:  Blood       Date:  1987-03       Impact factor: 22.113

3.  Activation of phospholipase D by protein kinase C. Evidence for a phosphorylation-independent mechanism.

Authors:  K M Conricode; K A Brewer; J H Exton
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

4.  Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. Differential effects of a novel protein kinase inhibitor.

Authors:  C Gerard; L C McPhail; A Marfat; N P Stimler-Gerard; D A Bass; C E McCall
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

5.  Peroxides of vanadate induce activation of phospholipase D in HL-60 cells. Role of tyrosine phosphorylation.

Authors:  S Bourgoin; S Grinstein
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

6.  Guanine-nucleotide- and adenine-nucleotide-dependent regulation of phospholipase D in electropermeabilized HL-60 granulocytes.

Authors:  M S Xie; G R Dubyak
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

7.  Tyrosine phosphorylation is involved in receptor coupling to phospholipase D but not phospholipase C in the human neutrophil.

Authors:  I J Uings; N T Thompson; R W Randall; G D Spacey; R W Bonser; A T Hudson; L G Garland
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

8.  Phospholipase D activation in a cell-free system from human neutrophils by phorbol 12-myristate 13-acetate and guanosine 5'-O-(3-thiotriphosphate). Activation is calcium dependent and requires protein factors in both the plasma membrane and cytosol.

Authors:  S C Olson; E P Bowman; J D Lambeth
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

9.  Stimulated neutrophils from patients with autosomal recessive chronic granulomatous disease fail to phosphorylate a Mr-44,000 protein.

Authors:  A W Segal; P G Heyworth; S Cockcroft; M M Barrowman
Journal:  Nature       Date:  1985 Aug 8-14       Impact factor: 49.962

10.  fMet-Leu-Phe-induced activation of phospholipase D in human neutrophils. Dependence on changes in cytosolic free Ca2+ concentration and relation with respiratory burst activation.

Authors:  G C Kessels; D Roos; A J Verhoeven
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

View more
  12 in total

1.  Endomorphin-2 modulates productions of TNF-alpha, IL-1beta, IL-10, and IL-12, and alters functions related to innate immune of macrophages.

Authors:  Yasutaka Azuma; Kiyoshi Ohura
Journal:  Inflammation       Date:  2002-10       Impact factor: 4.092

2.  Neutrophil superoxide-anion generating capacity in chronic smoking: effect of long-term alpha-tocopherol therapy.

Authors:  Lambertus J H van Tits; Frouwkje de Waart; Heidi L M Hak-Lemmers; Jacqueline de Graaf; Pierre N M Demacker; Anton F H Stalenhoef
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

3.  Interaction of respiratory burst and uptake of dehydroascorbic acid in differentiated HL-60 cells.

Authors:  H Laggner; H Goldenberg
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

4.  An apparently novel protein of human leukocytes, reactive with an antibody to protein kinase C-gamma, is rapidly modified upon cell activation: initial characterization in neutrophils and their cytoplasts.

Authors:  J I Smallwood; S E Malawista
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

5.  In vitro and in vivo impact of a new glycosphingolipid on neutrophils.

Authors:  E Tubaro; C Croce; G Cavallo; L Belogi; G Guida; C Santiangeli; M G Cifone; A Santoni; F Mainiero
Journal:  Agents Actions       Date:  1994-10

6.  Early signalling events implicated in leukotriene B4-induced activation of the NADPH oxidase in eosinophils: role of Ca2+, protein kinase C and phospholipases C and D.

Authors:  R S Perkins; M A Lindsay; P J Barnes; M A Giembycz
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

7.  Inhibition by gomisin C (a lignan from Schizandra chinensis) of the respiratory burst of rat neutrophils.

Authors:  J P Wang; S L Raung; M F Hsu; C C Chen
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

8.  Molecular mechanisms of N-formyl-methionyl-leucyl-phenylalanine-induced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable.

Authors:  Takanobu Sato; Tsunaki Hongu; Megumi Sakamoto; Yuji Funakoshi; Yasunori Kanaho
Journal:  Mol Cell Biol       Date:  2012-10-29       Impact factor: 4.272

9.  Pulmonary surfactant inhibits monocyte bactericidal functions by altering activation of protein kinase A and C.

Authors:  M F Geertsma; T P Zomerdijk; P H Nibbering; R van Furth
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

10.  The phosphorylation targets of p47phox, a subunit of the respiratory burst oxidase. Functions of the individual target serines as evaluated by site-directed mutagenesis.

Authors:  L R Faust; J el Benna; B M Babior; S J Chanock
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.